Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories,...

FDA Recall #D-0107-2018 — Class III — November 13, 2017

Recall #D-0107-2018 Date: November 13, 2017 Classification: Class III Status: Terminated

Product Description

Isradapine Capsules USP 2.5 mg, 100-count bottles, Rx only, Manufactured by: Elite Laboratories, Inc. Northvale, NJ 07647, NDC 42806-263-01, UPC 342806263013

Reason for Recall

Failed Impurities/Degradation Specifications

Recalling Firm

Elite Laboratories Inc. — Northvale, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

1264 bottles

Distribution

NY only

Code Information

Lot #: P0910-017, Exp. 05/2019

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated